MktsMarkets

Puma Biotechnology Inc
NASDAQ: PBYIKey statistics
PBYI News
Stories mentioning PBYI from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 44,814 | 75,453 | 54,475 | 52,436 | 46,007 | 59,077 | 80,542 | 47,083 |
| Cost of Goods Sold | 10,424 | 23,127 | 12,173 | 12,301 | 10,556 | 13,921 | 29,097 | 10,658 |
| Gross Profit | 34,390 | 52,326 | 42,302 | 40,135 | 35,451 | 45,156 | 51,445 | 36,425 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 18,423 | 18,379 | 16,817 | 18,047 | 17,604 | 16,622 | 16,819 | 24,972 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (3,828) | 17,106 | 9,573 | 6,636 | 3,984 | 13,365 | 22,079 | (2,179) |
| Interest Income | 1,002 | 977.00 | 1,044 | 956.00 | 1,101 | 1,226 | 1,282 | 1,244 |
| Interest Expense | ||||||||
| Other Expense | 130.00 | 143.00 | 115.00 | 410.00 | 359.00 | 268.00 | 347.00 | 156.00 |
| Pretax Income | (3,427) | 17,107 | 9,243 | 6,165 | 3,267 | 12,238 | 20,608 | (4,151) |
| Tax Provision | (7,067) | 291.00 | 378.00 | |||||
| Net Income (Loss) | (3,753) | 13,438 | 8,844 | 5,855 | 2,974 | 19,305 | 20,317 | (4,529) |
| Earnings Per Share (Basic) | (0.07) | 0.27 | 0.18 | 0.12 | 0.06 | 0.40 | 0.41 | (0.09) |
| Earnings Per Share (Diluted) | (0.07) | 0.27 | 0.17 | 0.12 | 0.06 | 0.39 | 0.41 | (0.09) |
| Weighted Average Shares Outstanding (Basic) | 50,845 | 50,011 | 50,339 | 49,700 | 49,596 | 48,649 | 49,008 | 48,292 |
| Weighted Average Shares Outstanding (Diluted) | 50,845 | 50,653 | 50,930 | 50,145 | 49,906 | 49,100 | 49,173 | 48,292 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About PBYI
Puma Biotechnology Inc (NASDAQ: PBYI) is a stock listed on the Nasdaq Stock Market under the ticker symbol PBYI. It last traded at $7.22 (Nov 18, 2026, 4:00 PM ET), up 1.1% on the day. That gives Puma Biotechnology a market capitalisation of $369.6M and a price-to-earnings ratio of 13.8.
Over the past 52 weeks PBYI has traded between $4.80 and $11.50.
Revenue for the quarter ended Mar 31, 2026 was $44.8M; a net loss of $3.8M. Revenue was down 2.6% from $46.0M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $44.8M | -$3.8M | -8.4% |
| Dec 31, 2025 | $75.5M | $13.4M | 17.8% |
| Sep 30, 2025 | $54.5M | $8.8M | 16.2% |
| Jun 30, 2025 | $52.4M | $5.9M | 11.2% |
From Puma Biotechnology’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…